跳至主要内容
临床试验/TCTR20170330003
TCTR20170330003招募中未知

Incidence of Subclinical and Clinical Acute Kidney Injury by a Novel Kidney Injury Biomarker, urine Neutrophil Gelatinase associated Lipocalin in Multidrug Resistant Septic Patients Treated with Colistimethate Sodium

Ratchadaphiseksomphot Endowment Fund0 个研究点目标入组 42 人开始时间: 2017年3月30日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
42

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 0 N/A (No limit)(—)
性别
All

入选标准

  • All patients over 18 years of age undergoing CMS treatment for more than 72 hours, eGFR ≥ 30 ml/min/1.73 m2 and hemodynamic stability

排除标准

  • CKD stage G4 and G5, ESRD on renal replacement therapy, AKI that required hemodialysis within 24 hours after CMS was prescribed and pregnant patients

研究者

发起方
Ratchadaphiseksomphot Endowment Fund

相似试验